1. Home
  2. BTBD vs RGNT Comparison

BTBD vs RGNT Comparison

Compare BTBD & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BT Brands Inc.

BTBD

BT Brands Inc.

N/A

Current Price

$1.10

Market Cap

10.0M

ML Signal

N/A

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.82

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTBD
RGNT
Founded
1987
2004
Country
United States
Israel
Employees
188
8
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
11.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BTBD
RGNT
Price
$1.10
$1.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
219.4K
6.7K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$1.93
52 Week High
$5.59
$8.35

Technical Indicators

Market Signals
Indicator
BTBD
RGNT
Relative Strength Index (RSI) 35.08 20.06
Support Level N/A N/A
Resistance Level $1.67 $3.35
Average True Range (ATR) 0.11 0.16
MACD -0.07 -0.04
Stochastic Oscillator 8.28 0.01

Price Performance

Historical Comparison
BTBD
RGNT

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: